In: PLOS ONE
10(1), e0115978
[PDF, 5MB]
Abstract
Human induced pluripotent stem cells (hiPSCs) represent a versatile tool to model genetic diseases and are a potential source for cell transfusion therapies. However, it remains elusive to which extent patient-specific hiPSC-derived cells functionally resemble their native counterparts. Here, we generated a hiPSC model of the primary platelet disease Glanzmann thrombasthenia (GT), characterized by dysfunction of the integrin receptor GPIIbIIIa, and compared side-by-side healthy and diseased hiPSC-derived platelets with peripheral blood platelets. Both GT-hiPSC-derived platelets and their peripheral blood equivalents showed absence of membrane expression of GPIIbIIIa, a reduction of PAC-1 binding, surface spreading and adherence to fibrinogen. We demonstrated that GT-hiPSC-derived platelets recapitulate molecular and functional aspects of the disease and show comparable behavior to their native counterparts encouraging the further use of hiPSC-based disease models as well as the transition towards a clinical application.
| Item Type: | Journal article |
|---|---|
| Faculties: | Biology > Department Biology I |
| Subjects: | 500 Science > 570 Life sciences; biology |
| URN: | urn:nbn:de:bvb:19-epub-34464-1 |
| ISSN: | 1932-6203 |
| Language: | English |
| Item ID: | 34464 |
| Date Deposited: | 15. Feb 2017 16:04 |
| Last Modified: | 04. Nov 2020 13:12 |

